NCT00555373 - Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Renal Transplant

Interventions

DRUG

Sirolimus

"1. Tacrolimus (Prograf®) At 6 months post-transplantation, patients will have Prograf® tapered by 25% per week such that they will be off of this medication by 7 months post-transplantation.~2. Sirolimus (Rapamune®):~At 6 months post-transplantation, all patients will be administered Sirolimus at a dose of 1.65-2.79 mg/m2/day as a tablet or liquid (administered q 12 hours)."

Trial Locations (4)

35205

Pediatric Nephrology of Alabama, Birmingham

90095

UCLA, Los Angeles

94305

Stanford University, Stanford

Unknown

Emory University, Atlanta